ASPN Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
49.8M
+31.6%
37.9M
-8.4%
41.3M
-43.4%
73.0M
-6.4%
78.0M
Cost of Revenue
46.6M
+38.6%
33.6M
-47.7%
64.3M
+23.1%
52.2M
-0.9%
52.7M
Gross Profit
3.3M
-23.7%
4.3M
+118.6%
-22929000
-210.2%
20.8M
-17.8%
25.3M
Operating Expenses
32.0M
+27.6%
25.1M
-14.3%
29.3M
+21.3%
24.1M
-20.8%
30.5M
R&D
3.2M
+17.3%
2.7M
-2.5%
2.8M
+12.1%
2.5M
-34.3%
3.8M
SG&A
19.9M
-9.2%
22.0M
+1.3%
21.7M
+8.0%
20.1M
-3.4%
20.8M
Operating Income
-28784000
-38.2%
-20834000
+60.1%
-52222000
-1459.8%
-3348000
+35.1%
-5155000
EBITDA
-24493000
-63.0%
-15025000
+21.9%
-19235000
-632.5%
3.6M
-44.7%
6.5M
Net Income
-23264000
+1.8%
-23691000
+67.5%
-72913000
-1051.1%
-6334000
+30.1%
-9056000
EPS (Basic)
$-0.28
+3.4%
$-0.29
+67.0%
$-0.88
-1000.0%
$-0.08
+27.3%
$-0.11
EPS (Diluted)
$-0.28
+3.4%
$-0.29
+67.0%
$-0.88
-1000.0%
$-0.08
+27.3%
$-0.11
Shares (Diluted)
82.9M
+0.2%
82.7M
+0.1%
82.7M
+0.3%
82.4M
+0.3%
82.2M
Aspen Aerogels (ASPN) โ€” Financials